A composition and related anti-viral uses thereof
NOVIR has the simultenaous ability to suppress DNA polymerase, ribonucleotide reductase and reverse transcriptase via rapid and simultenaous upregulation of tissue spesific cAMP and cGMP expression which leads to the potent suppression of above mentioned viral enzmyes. At the same time NOVIR has the ability to suppress pro-inflammatory cytokines such as TNF-A, cox-2, pge-2 and nf-kappaB expressions thus providing a double route treatment for both the cause and symptoms of viral infections.
our formulation is on the market with the trademark NOVIR. Trademark is registered on my name, Erdal Can Alkoclar as the 16 patents which currently protects our intellectual property rights. This product is an effective anti-viral treatment specially formulated for influenza but may possess required properties sufficient to become a candidate as an adjunctive treatment for AiDS and viral origined cancers. About 450-500 million people worldwide suffers from flu and other viral ailments.
TR20110010248
Turkey, 15 national applications 1 PCT applied patent
Sale
patent application
土耳其
